# NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.

> **NCT03752216** · PHASE4 · COMPLETED · sponsor: **ARCAGY/ GINECO GROUP** · enrollment: 141 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Niraparib

## Key facts

- **NCT ID:** NCT03752216
- **Lead sponsor:** ARCAGY/ GINECO GROUP
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-03
- **Primary completion:** 2021-08-18
- **Final completion:** 2022-12-13
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03752216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03752216, "NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03752216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*